FOSCARNET vs FOSFOMYCIN TROMETHAMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSCARNET vs FOSFOMYCIN TROMETHAMINE: Safety Overview
| Metric | FOSCARNET | FOSFOMYCIN TROMETHAMINE |
|---|---|---|
| Total FAERS Reports | 2,057 | 778 |
| Deaths Reported | 605 | 24 |
| Death Rate | 29.4% | 3.1% |
| Hospitalizations | 608 | 280 |
| Average Patient Age | 41.8 yrs | 59.2 yrs |
| % Female Patients | 40.6% | 83.9% |
| FDA Approval Date | Apr 21, 2021 | Dec 19, 1996 |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Cipla USA Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Discontinued |